Already in effect (January 1, 2026): Standard PA decisions within 7 calendar days (down from 14) Urgent PA decisions within 72 hours Specific denial reasons required on every denial (not just not medically necessary) Applies to Medicare Advantage, Medicaid managed care, CHIP, and ACA Marketplace plans Coming March 31, 2026: Payers must publicly report PA metrics for calendar year 2025: approval/denial rates, average decision times, and appeals outcomes Providers will be able to compare payer performance for the first time Coming January 1, 2027: FHIR-based Prior Authorization APIs required providers check PA requirements, submit requests, and receive decisions electronically through their EHR Expected to reduce average PA processing time from days to minutes for standard requests Medicare WISeR Model (live in AZ and WA): The Wasteful and Inappropriate Services Reduction pilot launched January 2026 in six states including Arizona and Washington

This comes on the heels of a recent study published in The New England Journal of Medicine that found the diabetes medication semaglutide resulted in significant weight loss in obesity patients
Safety concerns and effectiveness of long-term vitamin D and selenium use in endocrine disorders
Small, frequent meals for GLP-1 users Your stomach empties into your intestine slower when youre on a GLP-1
Glutathione injections are suitable for adults looking to improve skin clarity and overall antioxidant support
Combination of insulin with a GLP1 agonist is associated with better memory and normal expression of insulin receptor pathway genes in a mouse model of Alzheimers disease